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We have cloned two new triadin isoforms from 
rat skeletal muscle, Trisk 49 and Trisk 32, 
named according to their theoretical molecular 
weights, 49 kDa and 32 kDa respectively. 
Specific antibodies directed against each 
protein were produced to characterize both new 
triadins. Both are expressed in adult rat skeletal 
muscle, and their expression in slow twitch 
muscle is lower than in fast twitch muscle. 
Using double immunofluorescent labeling, the 
localization of these two triadins was studied in 
comparison to well characterized proteins such 
as ryanodine receptor, calsequestrin, desmin, 
Ca2+-ATPase, titin. None of these two triadins 
are localized within the rat skeletal muscle 
triad. Both are instead found in different parts 
of the longitudinal sarcoplasmic reticulum. We 
attempted to identify partners for each isoform: 
neither are associated with ryanodine receptor, 
Trisk 49 could be associated with titin or 
another sarcomeric protein, and Trisk 32 with 
IP3-receptor. These results open further fields 
of research concerning the functions of these 
two proteins, in particular they could be 
involved in the setting up and the maintenance 
of a precise sarcoplasmic reticulum structure. 
 
Skeletal muscle cells have highly organized 
structures. Sarcomeres, the contractile units of 
striated muscles, are assembled from thousands of 
proteins to produce the largest and most regular 
macromolecular complex known. In addition, this 
organized structure is designed to undergo strong 
mechanical stress during muscle contraction. 
Muscle contraction is activated by Ca2+ release 
from the sarcoplasmic reticulum in response to 
plasma membrane depolarization. This process is 
referred to as excitation-contraction coupling (E-C 
coupling), and takes place at the skeletal muscle 
triad junction, where T-tubules and the 
sarcoplasmic reticulum terminal cisternae are in 
close contact [1]. To perform its function, the 
sarcoplasmic reticulum is built as a sleeve-like 
structure around the myofibrils, and is 
compartmentalized in highly specialized structures 
(terminal cisternae, longitudinal reticulum) with 
specialized functions (calcium release and calcium 
uptake, respectively) [2].  
Calcium release occurs via a macromolecular 
complex, the calcium release complex, specifically 
localized in the skeletal muscle triad [3]. Major 
components of this calcium release complex are 
the two calcium channels, the ryanodine receptor 
(RyR) and the dihydropyridine receptor (DHPR) 
[4]. Triadin is an integral membrane protein of the 
sarcoplasmic reticulum, first identified in rabbit 
skeletal muscle in 1990 [5, 6] as a 95-kDa 
glycoprotein specifically located in the triads. 
Because of its co-localization with RyR in the 
triads, involvement of triadin in excitation-
contraction coupling has been presumed [7, 8]. 
Protein interaction studies have shown that 
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molecular partners of triadin are RyR [9, 10, 11], 
calsequestrin (CSQ), the protein which traps 
calcium inside the sarcoplasmic reticulum [12-14], 
junctin [15] and histidine-rich Ca2+-binding protein 
[16]. Functional studies have shown that triadin by 
itself is able to regulate the activity of the RyR 
calcium channel in vitro [11, 17].  
Triadin is expressed in both skeletal and cardiac 
muscle. Several isoforms of triadin have been 
identified in cardiac muscle. Three isoforms called 
CT1, CT2 and CT3 (Cardiac Triadin 1, 2, 3), with 
molecular weights of 35, 40 and 92-kDa 
respectively, have been cloned in rabbit heart [18]. 
Of these, CT1 (35-kDa) is the major triadin 
isoform expressed in canine heart muscle whereas 
CT2 (40-kDa) is not detectable as a protein, and 
CT3 (92-kDa) is expressed at very low levels in 
this species [19]. More recently, three triadin 
isoforms have been cloned from mouse heart 
muscle with molecular weights of 35, 35.5 and 40-
kDa [20]. While the 35-kDa and 40-kDa isoforms 
presumably correspond to CT1 and CT2 isoforms 
of rabbit heart muscle, the 35.5-kDa protein 
presumably represents a new isoform.  
We have previously shown that multiple isoforms 
of triadin are also expressed in rat skeletal muscle 
[21], and we identified a new skeletal muscle 
triadin isoform with an apparent molecular weight 
of 51-kDa. This new isoform was cloned from rat 
skeletal muscle [21] and from human skeletal 
muscle [22]. The skeletal muscle triadin isoforms 
were named according to their apparent molecular 
weights : Trisk (for TRIadin SKeletal) 95 for the 
95-kDa isoform, and Trisk 51 for the 51-kDa 
isoform. We have also shown that Trisk 95 and 
Trisk 51 are expressed in equivalent amounts in 
rabbit and rat skeletal muscles.  
In the present study, two new shorter rat skeletal 
muscle triadins were cloned, Trisk 49 and Trisk 
32. Specific antibodies were developed and used to 
characterize both proteins more precisely. The 
triadins’ expression patterns in fast and slow 
twitch muscles were studied, as well as during 
differentiation. The localization of these two 
triadins was studied with respect to other well 
characterized proteins localized in known regions 
of the sarcomere. This study demonstrates that 
both 49 kDa and 32 kDa triadins are not located 
within the triad, like Trisk 95 and Trisk 51, but are 
rather found in the longitudinal sarcoplasmic 
reticulum. Through double immunofluorescent 
labeling, this study precisely specifies their 
localization within the longitudinal sarcoplasmic 
reticulum, and identifies possible partners for each 
protein. This raises new questions concerning their 
possible function : Trisk 49 and Trisk 32 could be 
involved in the maintenance of sarcomere structure 
during contraction, and Trisk 32 could also be 
involved in the regulation of non triadic calcium 
release complex.  
 
Experimental procedures 
cDNA Cloning 
Total RNA was extracted from adult rat skeletal 
muscle using RNA-Plus (Q Biogene). mRNA were 
then purified twice using the Oligotex mRNA 
purification system (Qiagen). The first cDNA 
strand was synthetized by Superscript reverse 
transcriptase (Invitrogen) using the "Smart Race 
PCR cDNA Amplification" kit (Clontech, BD 
Biosciences), during 1h30 at 65°C in presence of 
0.6 M trehalose (Sigma-Aldrich) with the 3'-CDS 
primer 
(AAGCAGTGGTAACAACGCAGAGTAC(T)30 -
3’) and under all other conditions/products 
supplied in the kit. On the structural basis of 
triadin clone search (common 5'-end, and 
divergent 3'-end), a 3'-RACE PCR was performed 
with a common 5'-end primer, starting in the non-
coding sequence of triadin at –19 (5'-
ATTGATTTCTGCACCCACCATGACTGAG-3'), 
and extended toward the 3' divergent extremity up 
to the CDS primer used for reverse transcription 
(universal primer supplied in the kit: 5'- 
CTAATACGACTCACTATAGGGCAAGCAGT
GGTAACAACGCAGAGT-3'). PCR products 
were then subcloned using TA-cloning PGEM-T 
easy (Promega). Vectors containing inserts sized 
>1kb were then sequenced, resulting in the 
occurrence of two clones named 8F and 10D. 
 
Antibodies 
Anti-calsequestrin monoclonal antibody (clone 
VIIID12) was obtained from Affinity BioReagents. 
Mouse anti-IP3R-type III antibody was from 
Transduction laboratories (BD Biosciences). 
Monoclonal anti-desmin antibody (clone DE-R-11) 
was from DakoCytomation. Monoclonal anti-titin 
antibody (T11), specific to the A-I junction, 
originated from Abcam (Abcam limited, UK). 
Guinea pig anti Ca2+-ATPase was a gift from Dr. 
A.M. Lompré [23]. Rabbit anti-bovine 
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mitochondrial F1-ATPase antibody was previously 
characterized  [24]. Anti-ryanodine receptor 
antibodies (A-RyR), obtained by rabbit 
immunization with ryanodine receptor purified 
from pig skeletal muscle, have been described 
previously [4], as well as antibodies against Trisk 
95 and Trisk 51 [21], and antibodies against the N-
terminal end of triadins [25]. Using the same 
experimental techniques, anti-Trisk 49 and anti-
Trisk 32 have been produced. Anti-Trisk 49 results 
from rabbit immunization with the C-terminal 
peptide of Trisk 49, with an extra tyrosine residue 
added to its N-terminal end to allow coupling with 
ovalbumin (YSTTGKHS). Anti-Trisk 32 results 
from the immunization of a rabbit or guinea pig 
with the C-terminal peptide of Trisk 32, with an 
extra tyrosine residue added to its N-terminal end 
to allow coupling with ovalbumin 
(YGGPKRILDKKQI). Except for antibodies used 
against Trisk 49 and Trisk 32, all other antibodies 
used in this study have previously been 
characterized and used. 
 
Microsome preparation 
Two types of skeletal muscle were collected from 
adult rat hind legs: extensor digitorum longus 
(EDL) and soleus. Crude microsomes were 
prepared from each muscle with slight 
modifications to the procedures previously 
described [21]. Indeed, after muscle 
homogenization in a 30 ml solution made of 200 
mM sucrose, 20 mM HEPES (pH = 7.4), 0.4 mM 
CaCl2, 2 mM leupeptin, 100 mM PMSF, 1 mM 
DFP, the low speed (10 min at 1500 g) pellet was 
discarded, and the microsomes obtained after 50 
min centrifugation at 41 000 g. They were 
homogenized at 8-10 mg/ml in 0.1 M NaCl, 30 
mM Imidazole (pH 6.8), 8% sucrose, proteases 
inhibitors, and stored in liquid nitrogen.  
 
Satellite cell cultures 
Rat skeletal muscle cell primary cultures resulted 
from satellite cells obtained by trypsinization of 
muscle fragments extracted from 20 day old rat 
embryos. They were induced through 
differentiation and formed myotubes, as previously 
described [21]. 
 
L6 cell cultures and transfection 
Rat myogenic L6 cells (clone C5) were cultured in 
DMEM supplemented with 10% FBS (Invitrogen) 
and 1% PS. They were transfected with 
Lipofectamine and Plus Reagent (Invitrogen) as 
reported [21]. The expression plasmid used for 
transfection was plasmid pcDNA3.1 (Invitrogen), 
with cDNA coding for Trisk 49 (full length 
sequence of clone 10D) or Trisk 32 (full length 
sequence of clone 8F) . 
 
Western blot analysis 
The presence of Trisk 49 or Trisk 32 in samples 
was assayed by Western blot analysis, using a 
chemiluminescent reagent (Western lightning 
Chemiluminescence reagent plus, Perkin Elmer) 
after electrophoretic separation of the protein on a 
5-15% acrylamide gel, and electrotransfer  on 
Immobilon P (Millipore) [21].  The secondary 
antibodies were labeled with HRP and supplied by 
Jackson ImmunoResearch Laboratories. 
 
Immunolabelling 
Adult rat skeletal muscle (EDL) was embedded in 
Tissue-Tek O.C.T. compound (Miles Inc.), frozen 
and stored at -20°C. Cryosections (10 µm 
thickness) collected on microscope slides were 
fixed 10 min with 4% paraformaldehyde in PBS at 
RT, then washed 2 x 10 min with PBS at 4°C. 
After 5 min permeabilization with 0.5% Triton 
X100 in PBS at RT, and 30 min saturation with 
PBS supplemented with Triton X100 0.1%, 0.5% 
BSA and 2% goat serum, the sections were 
incubated for 2 h at RT with the primary 
antibodies (dilution 1/100 to 1/800) in PBS 
supplemented with 0.1% Triton X100, 0.5% BSA 
and 2% goat serum, and washed 3 x 10 min at 4°C 
with PBS-0.1% Triton X100. The sections were 
then incubated with secondary antibodies for 30 
min at RT. After 3 x 10 min washes in PBS-0.1% 
Triton X100 at RT, the nuclei were stained with 
TO-PRO-3 (Molecular Probes), and the samples 
were mounted with an anti-fading solution 
(DakoCytomation fluorescent mounting medium, 
DakoCytomation). For double labeling, the two 
primary antibodies (from different species) and the 
two secondary antibodies were added at the same 
time. The secondary antibodies were either labeled 
with Alexa-488, Alexa-546 (both from Molecular 
Probes), or Cy3 (from Jackson ImmunoResearch 
Laboratories). The muscle sections were analyzed 
by confocal laser scanning microscopy using a 
Leica TCS-SP2 operating system. Alexa-488, 
Alexa-546, or Cy3 fluorescence were sequentially 
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excited and collected (400 Hz line by line) by 
using a 488 nm argon laser line for Alexa-488, and 
a 543 nm helium-neon laser line for Alexa-546 and 
Cy3 excitation. Fluorescence emission was 
collected from 498 to 541 nm for Alexa-488, and 
from 554 to 625 nm for Alexa-546 and Cy3. To 
assess the specificity of some antibodies, the 
antibody was pre-incubated with the corresponding 
antigenic peptide for 1 h at RT, and a control was 
performed after incubation of the antibody with the 
corresponding antigenic peptide for 1 h at RT. 
For myotubes (differentiated satellite cells), the 
immunolabeling was performed directly in the 
culture plate. After fixation of the cells with a 4% 
paraformaldehyde solution for 15 min, and 2 x 5 
min washes with PBS, the cells were 
permeabilized 5 min with PBS - 0.25% Triton 
X100 and the immunolabeling was achieved 
similarly to that muscle sections. 
 
Immunoprecipitation 
Rat skeletal muscle microsomes or Trisk 32- 
transfected cells were solubilized for 30 min at 4°C 
at 3mg/ml in a buffer composed of 0.9M NaCl, 
1.6% CHAPS, 0.1% phospholipids (egg total 
phosphatide extract, Avanti Polar Lipids), 20mM 
Pipes (pH 7.1), PMSF 200µM, DFP 1mM. After 
solubilization, the solubilized proteins were diluted 
with 1 volume PBS and 1 volume H2O. The 
immunoprecipitation was then performed with the 
chosen antibody and protein-A sepharose as 
described previously [4]. The immunoprecipitated 
proteins were then analyzed by Western blotting. 
 
RESULTS 
 
Cloning of Trisk 49 and Trisk 32 
We have previously shown that multiple triadin 
mRNA are produced in rat skeletal muscle [21], 
and we have cloned two major triadin isoforms, 
Trisk 95 and Trisk 51, which correspond to 4.5 kb 
transcripts. We then went on with cloning the 
remaining smaller transcripts. 
The classic reverse transcription technique using 
oligo-dT18 failed to provide full length clones 
because of the presence of A-rich regions in the 
sequence of the cDNA, and only 3'-truncated 
clones were obtained. A more stringent technique 
was thus used to eliminate hybridization of the 
oligo-dT primer within the internal stretches of A 
in the region spanning triadin nucleotides 900 to 
1200. The reverse transcription step was performed 
with a 30-mer oligo-dT, at a temperature of 65°C, 
and in presence of trehalose to stabilize the reverse 
transcriptase at such a high temperature [26, 27]. 
In these conditions, most of the cDNAs produced 
by Superscript reverse transcriptase were full 
length clones, resulting from an oligo-dT 
hybridization only on the correct poly-A stretches. 
Two clones, named 10D and 8F, were further 
analyzed. Clone 8F contains an open reading frame 
of 864 bp followed by a non-coding sequence of 
127 bp with a polyadenylation signal. It encodes a 
287 amino acid protein with a molecular weight of 
32.1 kDa, and was thus named Trisk 32 according 
to its molecular weight (TRIadin SKeletal muscle 
32 kDa), as proposed for the two other skeletal 
muscle triadins Trisk 95 and Trisk 51. Trisk 32 
results from an alternative splicing after the 8 first 
exons of human triadin [22], and possesses a 
unique C-terminal end made of 23 amino acids 
(figure 1). The size of this triadin isoform is 
similar to CT1, the major cardiac triadin [19]. CT1 
is nevertheless distinct from Trisk 32, even though 
both result from alternative splicing after exon 8, 
as Trisk 32 has a different specific C-terminal end 
(figure 1). 
Clone 10D, containing an open reading frame of 
1326 bp and a short non-coding sequence of 24 bp 
with a polyadenylation signal, encodes a protein of 
442 amino acids, and results from an alternative 
splicing after the 20 first exons of human triadin. It 
possesses a unique C-terminal end of 4 amino 
acids (figure 1). The corresponding protein formed 
of 442 amino acids has a theoretical molecular 
weight of 49.5 kDa, and was thus named Trisk 49.  
 
Evidence for the existence of Trisk 49 and Trisk 32 
In order to check that the cloned cDNA are 
physiologically translated in the corresponding 
proteins, specific antibodies were produced for 
each isoform. Taking advantage of their C-terminal 
specific sequences, synthetic peptides were 
produced and used to immunize either rabbits or 
guinea pigs. Reactivity of these antibodies was 
first checked on cells transfected with the 
corresponding cloned cDNA (figure 2A), and then 
on rat skeletal muscle (figure 2B).  
Transfection of L6 cells with Trisk 32 cDNA gave 
rise to a triplet of approx. 37 kDa, specifically 
recognized by anti-T32 antibodies (figure 2A, lane 
1). Transfection of L6 cells with Trisk 49 cDNA 
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gave rise to a unique band of approx. 60 kDa, 
specifically recognized by anti-T49 antibodies 
(figure 2A, lane 3). The multiple bands observed 
for Trisk 32 are thought to arise from post-
transcriptional modifications (such as 
glycosylation), as a single cDNA leads to the 
expression of two/three proteins, a situation that 
has previously been observed for Trisk 51 
expressed in L6 cells [21], and for cardiac triadin 
CT1 expressed in Sf21 insect cells [19].  
These antibodies were then tested by Western blot 
analysis on rat skeletal muscle, in order to identify 
the corresponding protein within skeletal muscle. 
Anti-Trisk 32 specifically recognizes a triplet 
within rat skeletal muscle (figure 2B, lane 1), 
which was abolished by pre-incubation with the 
corresponding peptide (figure 2B, lane 2). Anti-
Trisk 49 antibodies recognized a faint but specific 
band in rat skeletal muscle (figure 2B, lane 3), as 
shown by the abolition of the signal upon 
antibody-peptide pre-incubation (figure 2B, lane 
4). Using anti-Nterminal end antibodies, common 
to all triadin isoforms and which thus allow 
relative quantification, this study showed that 
Trisk 32 is present in about the same quantities as 
Trisk 95 and Trisk 51 (figure 2C). Since Trisk 49 
migrates at the same molecular weight as Trisk 51, 
it is impossible to tell the respective contributions 
of Trisk 51 and Trisk 49 in the observed band. 
Nevertheless, it is likely that Trisk 49 is a less 
abundant isoform compared to the other three, as 
observed from anti-Trisk 49 reactivity on rat 
microsomes (figure 2B), and from RT-PCR 
amplification (data not shown). 
 
Are these isoforms specific to muscle type ? 
Since at least four triadin isoforms are expressed in 
rat skeletal muscle (Trisk 95, Trisk 51, Trisk 49 
and Trisk 32), this study further investigated 
whether some of these isoforms are muscle type 
specific. Indeed, myosin and many other skeletal 
muscle proteins (for review, see [28]) are 
expressed under different isoform ("fast" or 
"slow") when they are localized in fast twitch or 
slow twitch muscles. Microsomes from two types 
of rat muscle were prepared, in order to test the 
reactivity of the different triadin antibodies : 
extensor digitorum longus (EDL), a fast twitch 
muscle, and soleus, a slow twitch muscle. As 
shown on figure 3, reactivity to all four isoforms is 
lower in rat slow twitch muscle compared to fast 
twitch muscle, with Trisk 49 being almost 
undetectable. Nevertheless, except for Trisk 49,  
none of these isoforms seem to be slow twitch or 
fast twitch specific proteins. Trisk 49 is present in 
low amounts in fast twitch muscle, and either its 
expression in slow twitch muscle decreases to 
reach detection limit of Western blot, or it is not 
expressed in slow twitch muscle.  
 
Localization  of Trisk 49 and Trisk 32 in adult 
skeletal muscle 
In order to identify the localization of the two new 
isoforms in rat skeletal muscle, 
immunohistolabeling of rat EDL longitudinal 
section was performed with different antibodies: 
RyR, CSQ, Trisk 95, Trisk 51, Trisk 49 and Trisk 
32. As previously observed [21], Trisk 95 and 
Trisk 51 perfectly co-localize with RyR and CSQ. 
Figure 4 presents images of the Trisk 95/RyR and 
Trisk 51/CSQ double labeling, indicating that 
these two isoforms are localized within the adult 
rat skeletal muscle triad. The same experiment was 
performed with anti-Trisk 49 and anti-Trisk 32. 
These two triadin isoforms presented a striated 
pattern perpendicular to the fiber axis when 
observed at low magnification  similarly to RyR, 
CSQ, Trisk 95, Trisk 51 (data not shown). 
Nevertheless, at higher magnification, results are 
completely different for the two isoforms: neither 
are co-localized with RyR or CSQ (figure 5), nor 
with Trisk 95, Trisk 51 or DHPR (data not shown), 
these 5 proteins being all co-localized. The 
staining for Trisk 49 appears as a double row of 
rods situated in the middle of the double row of 
dots observed for CSQ (figure 5 panels a, b, c). 
This staining is very intense and contrasts with the 
faint labeling observed in Western blot, probably 
because Trisk 49 is present in low amount but it is 
very concentrated in a precise part of the muscle. 
The staining for Trisk 32 shows a diffused band of 
dots in the middle of RyR staining (figure 5, panels 
d, e, f). In addition, localization of both isoforms is 
not similar, Trisk 32 being inside the labeling of 
Trisk 49 (figure 5, panels g, h, i). In order to map 
their localization more precisely, double 
immunolabelings were performed with anti-Trisk 
49 and anti-Ca2+-ATPase antibodies, anti-desmin 
or anti-titin (figure 6). Ca2+-ATPase is a protein 
specifically localized in the sarcoplasmic reticulum 
responsible for  the uptake of calcium by the 
sarcoplasmic reticulum [29], and mostly abundant 
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in the longitudinal part of sarcoplasmic reticulum. 
Desmin is considered as a marker of the Z-disc 
[30]. Titin is a giant protein (each molecule, 
extending from the Z-disc to the M-line, is more 
than 1 µm long) which controls the layout of the 
sarcomere, and by acting like a spring provides 
elasticity to the sarcomere (reviewed in [31]). The 
antibody used to label titin is specific to the A-I 
junction part of the molecule [32]. Trisk 49 is 
localized within the longitudinal sarcoplasmic 
reticulum, but it is not present in all the 
longitudinal reticulum as observed from overlay 
with Ca2+-ATPase labeling (figure 6, panels a, b, 
c). Comparison with desmin’s localization showed 
that it is centered on the Z disc, the double row of 
rods surrounding the Z line (figure 6, panels d, e, 
f). Trisk 49 seems more precisely co-localized with 
titin at the A-I junction (figure 6, panels g, h, i). 
In order to localize Trisk 32 more precisely, double 
labeling was performed with anti-Trisk 32 and 
anti-Ca2+-ATPase, anti-desmin, anti-IP3R-type III 
or anti-mitochondrial FoF1-ATPase. It has been 
demonstrated that IP3R is found within the 
longitudinal sarcoplasmic reticulum, at the Z-line 
[33], and FoF1-ATPase, a specific mitochondrial 
protein responsible for ATP synthesis, is localized 
in the inner membrane of mitochondria [34]. Trisk 
32 is localized within the longitudinal 
sarcoplasmic reticulum (figure 7, panels a, b, c), 
where it co-localizes with Ca2+-ATPase, and is 
specifically centered on the Z-disc (co-localization 
with desmin, figure 7, panels d, e, f). Trisk 32 is 
also present in the same part of the reticulum as 
IP3R (figure 7, panels g, h, i), and as the 
mitochondria (figure 7, panels j, k, l). 
 
Identification of Trisk 32 and Trisk 49 partners 
We attempted to identify the specific partners of 
Trisk 32 and Trisk 49 using immunoprecipitation 
with specific antibodies, and their association with 
RyR was first investigated. As expected, RyR was 
neither associated with Trisk 49 nor with Trisk 32 
(or only in very minor amounts), in contrast with 
Trisk 95 and Trisk 51 which are both associated 
with RyR (figure 8A). Based on the possible co-
localization observed in immunolabeling, 
association of Trisk 32 with IP3R was also 
examined. Since IP3R is a protein that shares 
homologous domains with RyR, and since Trisk 32 
shares common parts with Trisk 95, which is 
associated with RyR, one could assume that Trisk 
32 and IP3R are not only partially co-localized, but 
also associated. Nevertheless, it was not possible 
to demonstrate IP3R’s association with Trisk 32 by 
immunoprecipitation on rat skeletal muscle, 
probably because of the low expression of IP3R in 
skeletal muscle [35, 36]. Thus, in order to test this 
hypothesis, skeletal muscle culture cells (L6 cells) 
were used, as they are known to express high 
amounts of IP3R-type III [36, 37]. These cells were 
transfected with Trisk 32 cDNA, or with Trisk 49, 
Trisk 51 or Trisk 95 cDNAs. Then the 
immunoprecipitation was performed with 
antibodies directed against the corresponding 
triadin isoform (A-Trisk 32, A-Trisk 49, A-Trisk 
51 or A-Trisk 95). The presence of IP3R-III among 
the immunoprecipitated proteins was assayed by 
Western blot analysis. Results are presented in 
figure 8B. IP3R-type III is expressed in the L6 
cells, as observed in lane 1. Immunoprecipitation 
was performed on Trisk 32 transfected (lanes 3 and 
5) or non-transfected (lanes 2 and 4) cells, with 
two different antibodies directed against Trisk 32 
(guinea pig anti-T32, lanes 2 and 3, or rabbit anti-
T32, lanes 4 and 5). Both anti-T32 antibodies 
induced co-immunoprecipitation of IP3R-III only 
in cells expressing Trisk 32. In the cells transfected 
with another triadin isoform, the 
immunoprecipitation of this triadin didn't lead to 
the co-immunoprecipitation of IP3R-III (figure 8B, 
lanes 6, 7 and 8). This indicates that Trisk 32 and 
IP3R-III are associated within the cells, and that the 
other triadin isoforms (Trisk 49, Trisk 51 and Trisk 
95) are unable to interact with IP3R-III. The 
association with IP3R-III is therefore specific of 
Trisk 32. It is thus plausible that in skeletal 
muscle, not only are Trisk 32 and IP3R co-
localized, but also associated. 
As titin and Trisk 49 appear co-localized on 
muscle sections, co-immunoprecipitation on rat 
micorosomes of titin and Trisk 49 was also 
attempted, using either anti-titin or anti-Trisk 49 
antibodies, but without success. This is probably 
due either to the low expression of Trisk 49 in 
skeletal muscle (figure 3), or to the microsome 
preparation which could lead to dissociation of the 
complex, as both proteins are expressed in 
different compartments. 
 
Trisk 49 and Trisk 32 expression during in vitro 
myotube differentiation  
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We have previously shown that Trisk 95 and Trisk 
51 are progressively expressed in primary cultures 
of rat skeletal muscle as differentiation and 
myotube formation takes place. Expression of 
Trisk 49 and Trisk 32 was examined during in 
vitro differentiation of rat myoblast primary 
cultures. The cells were identified by nuclei 
staining (represented in blue on figure 9, panels c 
and f). The myotubes were identified through 
nuclei alignment, while other cells remained as 
myoblasts or fibroblasts. Similarly to Trisk 95 and 
Trisk 51, Trisk 49 is not expressed within 
myoblasts, but within myotubes (figure 9, panel b). 
As soon as myotubes are formed, Trisk 49 is 
present under a striated pattern (figure 9, panel b), 
identical to the pattern observed for titin (figure 9, 
panel a). This striated pattern is specific to the 
protein and abolished by pre-incubation of 
antibodies with the peptide (data not shown). Trisk 
49’s early striated pattern is another indication 
towards a possible interaction with titin, and 
probably reflects a specific role and interaction at 
this early developmental stage. 
On the contrary, Trisk 32 shows punctuate labeling 
in myotubes (figure 9 panel e), similar to 
observations for Trisk 95 and Trisk 51, and it is 
expressed at a low level in myoblasts. This 
punctuated staining in myotubes is already co-
localized with IP3R-type III (figure 9, panels d, e 
and f inserts). 
 
DISCUSSION 
 
In this study, two new triadin isoforms, Trisk 49 
and Trisk 32, were cloned from rat skeletal muscle, 
and the presence of the corresponding protein was 
demonstrated using specific antibodies. While 
Trisk 32 is present in comparable amounts with the 
two previously described isoforms, Trisk 95 and 
Trisk 51, Trisk 49 is apparently less abundant. No 
isoform switch was observed between slow or fast 
twitch muscles. All triadin isoforms seemed less 
abundant in slow twitch muscle, probably because 
the relative amount of sarcoplasmic reticulum is 
lower in slow twitch muscle than in fast twitch 
muscle [38].  
Analysis of the cellular distribution of these two 
triadin isoforms in rat skeletal muscle showed that, 
in contrast with Trisk 95 and Trisk 51, Trisk 49 
and Trisk 32 are not located within the skeletal 
muscle triad. Since all triadins share common 
sequences, the localization of the triadins inside 
the muscle cell is somehow connected to the 
specific C-terminal end of each isoform. While it 
could be concluded that the name "triadin", in its 
original meaning "located in the triad", is not fully 
appropriate for these two triadin isoforms, it 
nevertheless should be kept because all triadin 
proteins result from alternative splicings of the 
same gene. These results were confirmed by 
immunoprecipitation, and once again it was 
observed that Trisk 95 and Trisk 51 are associated 
with RyR, and thus members of the calcium 
release complex, whereas no association was 
shown for Trisk 49 and Trisk 32. Their 
involvement in the calcium release complex or 
excitation-contraction coupling is still unclear. In 
order to find clues regarding their function, their 
precise localization was investigated in skeletal 
muscle. Using double immunofluorescent labeling 
on skeletal muscle sections, it was shown that 
Trisk 32 is localized within the longitudinal part of 
the sarcoplasmic reticulum, close to the Z-line. 
This part of the SR which has already been shown 
to contain IP3R, the other intracellular calcium 
channel [33, 39], and we indeed observed that 
Trisk 32 and IP3R are located within the same 
region of the sarcoplasmic reticulum. The similar 
localization of these two proteins enabled 
speculation concerning the existence of a calcium 
release complex centered around IP3R and 
involving Trisk 32, identical to the one centered 
around RyR and involving Trisk 95 and Trisk 51. 
This hypothesis was reinforced by sequence 
homologies identified between RyR and IP3R in 
the channel domains of both proteins [40, 41]. This 
domain of RyR has recently been demonstrated to 
be an interaction site between RyR and triadin 
[42]. Thus it is tempting to conclude towards a 
Trisk 32 - IP3R interaction. In order to test this 
hypothesis, immunoprecipitation was performed 
on a rat skeletal muscle cell line, known to express 
higher amount of IP3R than differentiated cells or 
adult muscle, transfected with Trisk 32 cDNA. 
Within the transfected cells, results showed that 
immunoprecipitation of Trisk 32 induced co-
immunoprecipitation of IP3R-type III. Thus 
association of Trisk 32 and IP3R-type III can be 
observed if both partners are expressed in 
reasonable amounts. This interaction is specific of 
Trisk 32 and can not be reproduced with the other 
triadin isoforms, Trisk 49, Trisk 51 or Trisk 95. 
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We conclude that this association could probably 
also exist in skeletal muscle, and part of Trisk 32 
could be associated with IP3R-III. By double 
labeling a muscle section with anti-Trisk 32 
antibodies and antibodies directed against a 
specific mitochondrial protein (FoF1-ATP 
synthase), it was observed that the part of the SR 
which contains Trisk 32 also co-localized with the 
mitochondria. The function of Trisk 32 could then 
be connected to calcium release via IP3R and/or 
calcium storage in the mitochondria, which is 
today a well established fact [43-46]. 
Double immunofluorescence labeling was also 
used to study the precise localization of Trisk 49. 
As early as the first developmental stages, Trisk 49 
differs in its localization from other triadin 
isoforms. Exterior to the triad, it is organized in a 
double row of rods localized between the double 
row of triads and the Z line. This localization 
corresponds to the A-I part of titin, a giant protein 
involved in the organization and elasticity of the 
sarcomere. Because of Trisk 49’s low expression 
in skeletal muscle, identification of its molecular 
partners has not yet been achieved, but will be the 
focus of future research.     
As previously observed for Trisk 95 and Trisk 51, 
the two new triadins Trisk 49 and Trisk 32 are 
strongly expressed in myotubes. Whereas Trisk 95, 
Trisk 51 and Trisk 49 are absent from myoblasts, 
Trisk 32 seems to have an earlier expression and is 
weakly expressed before differentiation. Trisk 32 
presents a punctuated pattern in myotubes, co-
localized with IP3R-III, whereas Trisk 49 presents 
a striated pattern, identical to the one observed for 
titin. Once again, this could be an indication that 
Trisk 32 is associated with IP3R, and Trisk 49 is 
associated with titin, ever since the early 
differentiation stages. Trisk 49 has already reached 
an organized localization compared to the Z-line, 
while the triads have not. Trisk 49 could be 
directly or not connected to the A-I part of titin, or 
connected to another sarcomeric protein localized 
in this region. It could then be involved in 
sarcomeric structures positioning and in 
organization of the triads. 
Figure 10 summarizes data concerning the 
localization of Trisk 32 and Trisk 49 in rat skeletal 
muscle. The next step will involve a more precise 
identification of their function, which in contrast to 
Trisk 95 and Trisk 51, will probably not be 
connected to excitation-contraction coupling. 
Because of its similar localization and possible 
interaction with IP3R, Trisk 32 could be involved 
in the regulation of a calcium release complex 
centered on IP3R, in a similar fashion as the 
regulation of the calcium release complex centered 
on RyR by Trisk 95. Trisk 32 is already expressed 
in myoblasts, as well as IP3R, in contrast to Trisk 
95 or Trisk 51 which, as RyR, are expressed only 
in myotubes. One possible role for these two 
triadin isoforms could involve an anchoring 
function. During contraction, elasticity of muscle 
fibers is such that, in order to remain organized, 
some parts have to be anchored while others are 
mobile. Position of the triads is fixed compared to 
the Z-line [47]. It is likely that all sarcoplasmic 
reticulum around the Z-line is fixed, including the 
triads, and mitochondria. As opposed, the 
sarcoplasmic reticulum centered around the 
myosin undergoes muscle contraction and 
elongation. In this context, the function of Trisk 32 
in a “fixed” sarcoplasmic reticulum could be 
related to the anchoring of the reticulum and IP3R 
to adjacent mitochondria. Similarly, Trisk 49 could 
be involved in connecting titin or another 
sarcomeric protein to the reticulum close to the 
triad. Thus, both triadins Trisk 49 and Trisk 32 
could contribute to maintaining this part of the 
reticulum stable during contraction. The existence 
of a cytoskeleton spatially separated from the 
contractile apparatus is increasingly recognized 
today [48]. A great number of proteins are 
involved in connecting the plasma membrane with 
the sarcomere Z-line at costamere [49]. Others are 
involved in connecting the sarcoplasmic reticulum 
to the myofibrils (see [50] for review), like ankyrin 
[51], or in connecting the plasma membrane to the 
sarcoplasmic reticulum membrane, like 
junctophilin [52]. Disruption to any of these 
systems has dramatic consequences on muscle and 
triad structure or function [52, 53], similarly to 
conditions observed in some myopathies.  Thus the 
putative function of Trisk 32 and Trisk 49 in 
maintaining sarcoplasmic reticulum positioning 
could be of major importance and needs to be 
researched thoroughly. In addition, the presence of 
these two triadin in human skeletal muscle has to 
be assayed.  
Another muscle protein, tropomyosin, has recently 
been discovered under different isoforms in 
various localizations of the skeletal muscle, either 
associated with thin actin filaments, or with the Z-
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line [54]. Thus, triadins are likely to be part of a 
large family of skeletal muscle proteins which can 
have multiple localizations and functions within 
the same cell. Different types of reticulum exist 
within skeletal muscle, and it would be worth 
identifying which type of reticulum (endoplamic, 
sarcoplasmic,…) these triadins are located in, in 
order to understand their sorting and function [55].  
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FOOTNOTES 
 
The sequences presented in this manuscript have been submitted to EMBL Nucleotide Sequence 
Database, and are accessible through EMBL Accession Number AJ812275 and EMBL Accession Number 
AJ812276. 
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FIGURE LEGENDS 
 
Figure 1: Sequence alignment of the C-terminal specific sequences of Trisk 32 and Trisk 49 with Trisk 
95, Trisk 51 and mouse CT1 (cardiac isoform). Amino acids within the box represent the conserved 
sequences between the different isoforms. Upper numbers correspond to amino acid positions in the Trisk 
95 sequence. 
 
Figure 2 : Western blot analysis of Trisk 32 and Trisk 49 
Panel A: L6 cells transfected with Trisk 32 or Trisk 49 cDNA. Fifty micrograms of cell lysates were 
loaded in each lane. Lane 1: L6 transfected with Trisk 32. Lanes 2 and 4: non transfected L6 cells. Lane 3: 
L6 transfected with Trisk 49. Western blot analysis was performed with anti-Trisk 32 (lanes 1 and 2) or 
anti-Trisk 49 (lanes 3 and 4). 
Panel B: Identification of Trisk 32 and Trisk 49 in rat skeletal muscle. Forty micrograms of rat skeletal 
muscle microsomes were loaded in each lane. Western blot analysis was performed with anti-Trisk 32, 
without (lane 1) and with (lane 2) pre-incubation of the antibody with the corresponding peptide (10 
µg/ml). Western blot analysis in lanes 3 and 4 was performed with anti-Trisk 49, without (lane 3) and with 
(lane 4) pre-incubation with the corresponding peptide (10 µg/ml).  
Panel C: Western blot analysis of rat skeletal muscle with an antibody directed against the N-terminal end 
of triadin, common to all triadin isoforms. Five micrograms of rat skeletal microsomes were loaded. The 
three major bands correspond to Trisk 95, Trisk 51 and Trisk 32. 
 
Figure 3: Expression of triadin isoforms in slow twitch and fast twitch muscle 
The relative amount of each triadin isoform was assessed by Western blot analysis on slow twitch muscle 
(soleus, lanes 1, 3, 5, 7) and on fast twitch muscle (EDL, lanes 2, 4, 6, 8). Twenty micrograms 
microsomes from both muscle types were loaded in each lane, except for lane 5, where 40 µg of soleus 
microsomes were loaded. Analysis was performed with antibodies against Trisk 95 (A-T95, lanes 1 and 
2), against Trisk 51 (A-T51, lanes 3 and 4), against Trisk 49 (A-T49, lanes 5 and 6), and against Trisk 32 
(A-T32, lanes 7 and 8). 
 
Figure 4: Co-localization of RyR and T95, and of CSQ and T51 in rat skeletal muscle sections. 
Longitudinal sections of adult rat EDL were immunolabeled with specific antibodies against RyR and 
Trisk 95 (T95), and CSQ and Trisk 51 (T51). They presented the typical triad protein labeling pattern: 
double rows of fluorescent dots corresponding to triads pairs on either side of the Z-line. 
 
Figure 5: Trisk 49 and Trisk 32 are not in rat skeletal muscle triad. 
Longitudinal sections of adult rat EDL were immunolabeled with specific antibodies against CSQ and 
Trisk 49 (T49) (panels a, b, c), RyR and Trisk 32 (T32) (panels d, e, f) or Trisk 49 and Trisk 32 (panels g, 
h, i). Trisk 49 labeling (panel b) is presented as a double row of rods, closer to the Z-line than the triads 
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are (represented by CSQ labeling, panel a). Trisk 32 labeling (panel e) appears as a row of dots in the 
middle of the triad double rows. 
 
Figure 6: Trisk 49 is localized within the longitudinal sarcoplasmic reticulum, at the interface of the 
A and I bands. 
Longitudinal sections of adult rat EDL were immunolabeled with specific antibodies against Ca2+-ATPase 
and Trisk 49 (panels a, b and c), desmin and Trisk 49 (panels d, e and f), and titin and Trisk 49 (panels g, h 
and i). Ca2+-ATPase is a longitudinal sarcoplasmic reticulum marker, desmin labels the Z-line, and 
antibodies used against titin are specific to the A-I interface. 
 
Figure 7: Trisk 32 is located within the longitudinal sarcoplasmic reticulum, co-localized with IP3R 
and mitochondria. 
Longitudinal sections of adult rat EDL were immunolabeled with specific antibodies against Ca2+-ATPase 
and Trisk 32 (panels a, b and c), desmin and Trisk 32 (panels d, e and f), IP3R and Trisk 32 (panels g, h 
and i), and FoF1-ATPase and Trisk 32 (panels j, k and l). Ca2+-ATPase is a longitudinal sarcoplasmic 
reticulum marker, desmin labels the Z-line, IP3R is located in the longitudinal sarcoplasmic reticulum, and 
FoF1-ATPase is a mitochondria marker. 
 
Figure 8:  A -Trisk 95 and Trisk 51, and not Trisk 32 nor Trisk 49, are associated with RyR. 
Immunoprecipitations were performed on rat skeletal muscle with antibodies against Trisk 95 (IP-T95, 
lane 2), against Trisk 51 (IP-T51, lane 3), against Trisk 32 (IP-T32), against Trisk 49 (IP-T49), and with 
non-immune serum (pre-immune : IP-PI). The presence of RyR in the immunoprecipitated proteins was 
analyzed by western blot. Lane 1: 5 µg of rat skeletal muscle microsomes. The two bands with high 
molecular weights are characteristic of RyR, the lower one, present in smaller amount, being a proteolytic 
degradation of RyR. 
B- Trisk 32, but not Trisk 49, Trisk 51 or Trisk 95, is associated with IP3R in L6 cells 
L6 cells were transfected (lanes 3 and 5) or not (lanes 2 and 4) with Trisk 32 cDNA, or transfected with 
the cDNA of Trisk 49 (lane 6), Trisk 51 (lane 7) or Trisk 95 (lane 8). Immunoprecipitations were then 
performed with the corresponding anti-Trisk antibody (anti-Trisk 32 developed in guinea pig, lanes 2-3; 
anti-Trisk 32 developed in rabbit, lanes 4-5;  anti-Trisk 49, lane 6; anti-Trisk 51, lane 7 and anti-Trisk 95, 
lane 8). The immunoprecipitated proteins were analyzed by western blot using anti-IP3R antibodies. Lane 
1: 60 µg of non-transfected L6 cells, for control of IP3R-type III expression levels 
 
Figure 9: Trisk 49 and Trisk 32 expression during differentiation of myoblasts. 
Primary cultures of satellite cells were induced in differentiation. When myotubes formed, the cells were 
fixed and labeled with antibodies against titin and Trisk 49 (panels a, b and c), or IP3R and Trisk 32 
(panels d, e and f). The nuclei were stained with TO-PRO 3 (blue labeling in panels c and f). Titin and 
Trisk 49 antibodies labeled only myotubes (aligned nuclei) and not myoblasts (isolated nuclei), and both 
presented a striated pattern. IP3R and Trisk 32 antibodies label the myotubes (multinucleated cells) and the 
myoblasts (isolated nuclei), with a diffuse punctuated pattern. 
 
Figure 10: Schematic organization of the triad area and localization of Trisk 49 and Trisk 32. 
Possible organizations of the sarcoplasmic reticulum and triad, and localization of Trisk 49 and Trisk 32 
compared to other known proteins are represented on this figure. Both Trisk 49 and Trisk 32 are located at 
slightly different places within the non-junctional sarcoplasmic reticulum surrounding the Z-line, while 
triad proteins are found around the T-tubules. 
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Trisk 95 PKTTPKAREK DDKETPAVPK HEQKDQYAFC RYMIDMFVHG DLKPGQSPAV PPPSLTASRP
Trisk 32 PKTTPKAREK DDKETPAVPK HEQKGKLSKE EKEAVGGPKR ILDKKQI
Mouse CT1 QKT-PKPKEK ESKETAAVSK QEQKGKQSEE AAGCFKRTLG KKQMQ
421 480
Trisk 95 KAKAEQAKEE IAPASTKKAL HGKKEEKAKT VEQGKDVKPK LPQPQLKKEE KSEPQPKKEV
Trisk 51 KAKAEQAKEE IAPASTKKAL HGKKEEKAKT VEQGKKKSEA G
Trisk 49 KAKAEQAKEE IAPASTKKGK HS
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